Northwell Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwell Health sits in the top decile of US sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count).
Northwell Health: 370 sponsored US clinical trials, 81 recruiting.
Northwell Health sponsors 370 registered US clinical trials on ClinicalTrials.gov, 81 of them currently recruiting, and 209 completed. 38 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 8 trials.
Top-decile sponsor footprint
Northwell Health ranks in the top decile of sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
209 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
370 total, page 2 of 8
taVNS for FRNS in Children
NCT05588063
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
NCT05643235
Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy
NCT05561907
A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
NCT05583942
Virtual Reality's Effect on Decreasing Pain and Subsequent Opioid Use in Pediatric Patients in the Post-Operative Period Following Scoliosis Repair
NCT05888038
Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study
NCT05350150
Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes
NCT05341544
Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
NCT05389787
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
NCT05384535
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers
NCT05606133
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
NCT05271240
A Pilot Study to Evaluate PureWick for Nocturia
NCT05090722
Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract
NCT04758624
Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk
NCT05131035
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
NCT05032781
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
NCT05287841
Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
NCT04685772
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
NCT04755699
Artificial Intelligence to Measure Adherence to Oral Medication
NCT04046497
Trial of Belimumab in Early Lupus
NCT03543839
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
NCT04005378
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
NCT04004364
Neural Biomarkers of Electroconvulsive Therapy Response
NCT04763655
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
NCT03587701
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
NCT03184545
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
NCT03213002
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
NCT02861898
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
NCT02800486
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
NCT01269853
Human Blood Cell Disorders Tissue Bank
NCT00902447
Diamond Blackfan Anemia Registry (DBAR)
NCT00106015
A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD
NCT06801912
BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRD
NCT06803797
Alcohol Cessation Among Head and Neck Cancer Survivors
NCT05570851
Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients
NCT07122479
Eatable Alphabet as a Nutrition Education Tool
NCT05166629
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
NCT07122466
Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
NCT05289167
Centrally Acting ACE Inhibition in SLE
NCT04486118
Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19
NCT04724720
The Young Heart Study
NCT04462159
Genotypic Influences on Network Progression in Parkinson's Disease
NCT04228172
Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease
NCT04094298
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
NCT03581877
MIPE for Pilonidal Disease
NCT03772873
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
NCT03630289
The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works
NCT03128268
Tissue Collection for Understanding Intervertebral Disc Degeneration and Back Pain
NCT01633034
Emotional Urinary Tract Infection
NCT07191041
Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT
NCT07675174
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 30 |
| Phase 3 | 12 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the Northwell Health pipeline
81 recruiting of 370 indexed (22% open); 209 completed (56%).
Phase mix: 38 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Schizophrenia (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwell Health: open-pipeline peers nationwide
Peers matched on 370 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 370 trials (± recruiting share)
- University of California, Irvine · 368 trials · 20% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
- New York State Psychiatric Institute · 364 trials · 3% recruiting
Sponsors near 22% open enrollment (± trial volume)
- St. Jude Children's Research Hospital · 22% recruiting · 410 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
- AtriCure · 22% recruiting · 23 trials
- University of Colorado, Boulder · 22% recruiting · 69 trials
Related
What to do with this Northwell Health page
370 registered trials is a research-attention snapshot, not an endorsement of Northwell Health or any single study.
- 81 of Northwell Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Schizophrenia is the condition Northwell Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Northwell Health pipeline card: 370 registered trials from official public datasets.Report a data error.